Patients With Severe Eosinophilic Asthma Treated With Benralizumab

Change in Patient-Reported Outcomes in Severe Eosinophilic Asthma Patients Treated With Benralizumab Under Real-life Conditions

NCT04184284 ·Status: COMPLETED

Patient-Reported OUTcomes of Benralizumab in Real-World Use in Severe EosiNophilic Asthma Patients

NCT05603845 ·Status: COMPLETED

Benralizumab in Patients With Inadequate Response to Anti-IL5 Monoclonal Antibody Therapies

NCT03470311 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation

NCT02869438 ·Status: COMPLETED ·Phase: PHASE3

Patient Reported Outcomes in Adults With Severe Eosinophilic Asthma on Benralizumab.

NCT03833141 ·Status: COMPLETED

Benralizumab Patient Access Programme Study: Retrospective Study in UK Severe Asthma Centres

NCT05932849 ·Status: COMPLETED

A Study of the Safety and Effectiveness of Benralizumab to Treat Patients With Severe Uncontrolled Asthma.

NCT03170271 ·Status: COMPLETED ·Phase: PHASE3

Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics

NCT03953300 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Benralizumab Exacerbation Study

NCT04102800 ·Status: COMPLETED ·Phase: PHASE4

Study to Evaluate the Effect of Benralizumab on Allergen-Induced Inflammation in Mild, Atopic Asthmatics

NCT02821416 ·Status: COMPLETED ·Phase: PHASE3

ChAracterisation of ItaliaN Severe Uncontrolled Asthmatic patieNts Key Features When Receiving Benralizumab

NCT04272463 ·Status: COMPLETED

PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma

NCT04305405 ·Status: COMPLETED ·Phase: PHASE3

Similarities and Differences of Biological Therapies for Severe Asthma.

NCT04665141 ·Status: UNKNOWN

A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)

NCT05692180 ·Status: RECRUITING ·Phase: PHASE3

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Participants With Severe Eosinophilic Asthma on Markers of Asthma Control

NCT02281318 ·Status: COMPLETED ·Phase: PHASE3

Real World Evidence of Benralizumab in Eosinophilic Severe AsThma in Russia (BEST)

NCT05271526 ·Status: COMPLETED

This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab

NCT06862206 ·Status: RECRUITING

A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy

NCT07214753 ·Status: RECRUITING

Effect of Benralizumab on Airway Remodeling in Asthma

NCT04365205 ·Status: RECRUITING

Effects of Anti-IL5 Biological Treatments on Blood IgE Levels in Severe Asthmatic Patients

NCT04181190 ·Status: COMPLETED

A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype

NCT04718389 ·Status: COMPLETED ·Phase: PHASE3

CT Air-trapping for the Early Identification of Benralizumab Responders Among Eosinophilic Asthma Patients

NCT03976310 ·Status: COMPLETED ·Phase: NA

Effect of Mepolizumab on Severe Eosinophilic Asthma

NCT04641741 ·Status: UNKNOWN

Benralizumab in the Treatment of Patients With Severe Asthma With ABPA

NCT04108962 ·Status: WITHDRAWN ·Phase: PHASE4

STEP: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With Severe Eosinophilic Asthma

NCT06465485 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3